semaj83/ctmatch_classification huggingface dataset:
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiac Catheterization All consented pts. over the age of 18 who received sutured mediated femoral vein following catheterization  Pt.s who are unable to give consent Pts. whose participation in research is contraindicated for medical reasons are excluded
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cardiac Arrest Hypothermia ROSC after SCA due to VF/VT or PEA/Asystolia GCS 3  Non-cardiac SCA Pregnancy Unstable Circulation instead of High-dose Inotropics Life-expectancy reducing concomitant illness
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Artery Disease, Autosomal Dominant, 1 Patient is > 18 years of age (or minimum age as required by local regulations) The patient or patient's legal representative has consented to participate and has authorized the collection and release of his medical information by signing the "Patient Informed Consent Form" All lesions requiring interventions (target lesions one to a maximum of four) in one or more native coronary arteries are amendable for implantation of one or more Endeavor® Zotarolimus Eluting Coronary Stent System Patient indication, lesion length and vessel diameter of the target lesion(s) are according to the 'Indications for Use' as mentioned in the 'Instructions for Use' that comes with every Endeavor® Zotarolimus Eluting Coronary Stent System. Please check the 'Instructions for Use' that comes with the product. Please be aware that the 'Instructions for Use' may be subject to change during the course of the study The patient is willing and able to cooperate with study procedures and required follow up visits  Women with known pregnancy or who are lactating Planned elective surgery necessitating discontinuation of clopidogrel within the regular planned period of clopidogrel administration Patients expected not to be compliant with the anti-platelet and/or anticoagulation therapy regimen Previous brachytherapy Previous implantation of a drug eluting stent Previous implantation of a bare metal stent in the preceding year Simultaneous or planned intervention other non cardiac vessels including but not limited to renal artery or carotid artery Current medical condition with a life expectancy of less than 3 years Manifest acute severe heart failure (Killip class III-IV) The patient is currently, and during the first 3 years of the trial, participating in another investigational device or drug study that clinically interferes with the endpoints; or requires coronary angiography or other coronary artery imaging procedures. The patient may only be enrolled in the once
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  Arterial Stiffness The patients receiving CRT are medically refractory, symptomatic, NYHA class III or IV disease and QRS duration of 130 m sec or greater, and a left ventricular ejection fraction of 30 percent or less All individuals are carefully selected after appropriate clinical evaluation as determined by the treating physicians to possible reversible causes of heart failure  Patients with permanent atrial fibrillation and non-palpable carotid and/or femoral pulses will be excluded due to technical limitations of the procedure used for the measurement of arterial stiffness
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Angiography Via Femoral Artery Access The patient must be at least 18 years old Patients undergoing femoral access coronary angiography Patient must be competent for providing informed, written consent Only 6F sheath  Percutaneous coronary intervention Intra coronary measurements (FFR, IVUS, OCT, NIR) Groin hematoma before closure Pseudoaneurysm or AV fistula Significant stenosis of ilial or femoral artery Prior peripheral artery surgery INR > 3,0 Platelet count < 120 million per millilitre blood Coagulopathy (bleeding disorder) Thrombolysis in the last 24h
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 30.0-80.0,  Diabetic Foot Ulcer diabetic foot ulcer < = 80 years old diabetic foot ulcer wegnar 2-4 stage  Wagner grade 0,1 and grade 5 severe coronary, cerebral, renal vascular as well as severe liver diseases, malignant neoplasms bleeding individuals > 80 years old heart failure (NYHA 3,4) cancer
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Coagulation Therapeutic Uses Pharmacologic Actions patient/legal representative provides written informed consent Patient is scheduled for a coronary or peripheral diagnostic or interventional procedure Target vessel has a lumen diameter ≥ 6 mm Patient must be willing to comply with follow-up requirements Patient has a 5-7F arterial puncture located in the common femoral artery  Arterial puncture in the femoral artery of both legs Manual compression has been preformed on the ipsilateral arterial site within the previous 6 weeks Any closure system has been used on the ipsilateral arterial site within the previous 180 days Any reentry of the ipsilateral site is planned within the next 6 weeks History of surgical repair of blood vessels of the ipsilateral arterial site Patient is unable to ambulate at baseline Significant bleeding diathesis or platelet dysfunction Thrombocytopenia (Plt count ≤ 100,000) Anemia (Hgb ≤ 10mg/dl and/or Hct ≤ 30mg/dl) Hemophilia
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 7.0-18.0,  Pain Ages 7-18 years Scheduled for cardiac catheterization through the femoral artery and/or vein under general anesthetic Ability to speak and understand English No apparent cognitive impairments  Known allergies to bupivacaine Impaired renal function Impaired hepatic function
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Diabetes Critical Limb Ischemia Adult diabetic patients type 1 or 2 Chronic critical ischemia as defined by TASC 2007 (pain at rest, and/or ulcer or gangrene due to arteriopathy: transcutaneous oximetry < 30 mmHg or pressure on the ankle < 70 mmHg)  Cancer with adverse prognosis in months, or chemotherapeutic treatment Ongoing or planned pregnancy Lack of consent to participate to the study
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Artery Disease Age > 19 years Subject is able to verbally confirm understanding of risks, benefits and treatment alternatives of receiving the drug-eluting stent(s) and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure Subject must have significant stenosis (>50% by visual estimate) on a native or in-stent coronary artery Subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, acute myocardial infarction, positive functional study or a reversible changes in the ECG consistent with ischemia). In subjects with coronary artery stenosis >75%, evidence of myocardial ischemia does not have to be documented  Subject has a known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, prasugrel, ticagrelor, biolimus A9, everolimus, zotarolimus, stainless steel, cobalt chromium, contrast media (Patients with documented sensitivity to contrast media, which can be effectively premedicated with steroid and diphenhydramine may be enrolled. However, those with true anaphylaxis to prior contrast media should not be enrolled.) Subject in use of systemic (intravenous) biolimus A9, everolimus or zotarolimus within 12 months Female subject of childbearing potential, unless a recent pregnancy test is negative, who possibly plans to become pregnant any time after enrollment into this study Subject planned an elective surgical procedure that would necessitate interruption of antiplatelet during the first 12 months post enrollment Subject with non-cardiac co-morbid condition with life expectancy < 2 year or that may result in protocol non-compliance (per site investigator's medical judgment) Subject with cardiogenic shock at presentation Subject who are actively participating in another drug or device investigational study, who have not completed the primary end point follow-up period
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Artery Disease Angina Pectoris Myocardial Infarction Age ≥18 years Symptomatic coronary artery disease including patients with chronic stable angina, silent ischemia, and acute coronary syndromes including NSTE-ACS and STE-ACS Presence of one or more coronary artery stenoses >50% in a native coronary artery or a saphenous bypass graft which can be treated with a stent ranging in diameter from 2.25 to 4.0 mm and can be covered with one or multiple stents No limitation on the number of treated lesions, and vessels, and lesion length  Pregnancy Known intolerance to aspirin, clopidogrel, heparin, stainless steel, Sirolimus, Everolimus or contrast material Inability to provide informed consent Currently participating in another trial before reaching first endpoint Planned surgery within 6 months of PCI unless dual antiplatelet therapy is maintained throughout the peri-surgical period
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Critical Care Catheterization Patient admitted in the Intensive Care Unit Requiring Central Venous Catheterization  Patients with only one site available
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Severe Sepsis Control group  male or female aged at least 18 years, matched on age, sex and cardiovascular risk factors (smoking, hypertension, diabetes and treated dyslipidemia) with septic patients Normal clinical examination and normal 12-lead ECG Routines biological tests in the normal range of the laboratories Body mass index between 18 and 27 kg/m² Written informed consent Patients group  Male or female aged at least 18 years Severe sepsis defined by the presence of a systemic inflammatory response syndrome  Control group  legal protection or persons deprived of liberty bacterial or viral infection in the month preceding current medication pregnancy or breastfeeding period stated on the national register for persons who participate to biomedical research Patients group  legal protection or persons deprived of liberty vasopressor therapy bacterial or viral infection in the month preceding
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 19.0-90.0,  Carotid Stenosis Femoral Arterial Stenosis Carotid Bruit Asymptomatic Carotid Murmur age 19-90 years having clinical ultrasound evaluation of carotid or femoral artery  under age 19; over age 90 years
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiac Disease Coronary Artery Disease Over 18 years of age Each patient, or his or her guardian or legal representative, is willing to give informed consent Clinically indicated for an intra-arterial procedure involving access through the common femoral artery and conducted through an access sheath size of between 6F and 7F inclusive  Patients with known allergy to any of the materials used in the device Severe acute non-cardiac systemic disease or terminal illness with a life expectancy of less than one year Evidence of systemic bacterial or cutaneous infection, including groin infection Patients suffering with definitive or potential coagulopathy or platelet count <100,000./µl Use of systemic thrombolytic agents within 24 hours prior to or during the catheterisation procedure which cause the concentration of fibrinogen to be < 100 mg/dl or if post-thrombolytic fibrinogen (in case of thrombolysis within 24 hours or intra-procedural) cannot be measured Patients in whom an introducer sheath smaller than 6F or greater than 7F have been used Currently participating in another investigational device or drug study Patients with severe claudication, iliac or femoral artery diameter stenosis greater than 50%, or previous bypass surgery or stent placement in the vicinity of the access site If puncture site is via a vascular graft If a palpable haematoma is observed during the procedure
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 16.0-60.0,  Vascular Postoperative Complications Urological System Complication of Procedure Lymphocele Postoperative Infection Patients candidates to renal transplantation  Patients with known allergy to products of fibrin seal
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-89.0,  Cardiac Diseases All cardiac surgical patients  Non cardiac surgery
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abdominal Aortic Aneurysm Carotid Atherosclerosis Critical Lower Limb Ischaemia Age greater than 18 years patient willing to give full informed consent for participation Patients undergoing elective carotid endarterectomy or Patients undergoing open abdominal aortic aneurysm repair or Patients undergoing endovascular abdominal aneurysm repair or Patients undergoing surgical lower limb revascularisation (suprainguinal or infrainguinal)  Patients less than 18 years of age Patients who are unable or unwilling to give full informed consent Pregnancy Significant upper limb peripheral arterial disease Patients on glibenclamide or nicorandil (these medications may interfere with remote ischaemic preconditioning) Patients with an estimated pre-operative glomerular filtration rate < 30mls/min/1.73m2 Patients with a history of myocarditis, pericarditis or amyloidosis Patients undergoing Fenestrated or branched EVAR
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Ischaemic Stroke Clinical diagnosis of supratentorial acute ischaemic stroke Male or nonpregnant female ≥18 years of age Clinically significant neurological deficit and NIHSS score ≥6 Eligible for IV rtPA according to standard guidelines and able to be commenced on IV treatment <4.5h after symptom onset Enrolment, randomisation and procedure commencement (groin puncture) possible within 90 minutes of the start of IV rtPA treatment (groin puncture maximum 5.5h after stroke onset) Occlusion of the main middle cerebral artery (MCA) trunk, MCA bifurcation or intracranial internal carotid artery(carotidT, M1 or single proximal M2 branch) demonstrated on CTA, MRA, or DSA Interventional device delivery (guide catheter placed beyond aortic arch and angio obtained) can be achieved within 6 hours of onset of the stroke Consent of patient or representative Independent prior to the stroke (estimated mRS 02) Expected to be able to be followed up at 3 months  CT evidence of intracranial haemorrhage, or evidence of extensive established hypodensity on CT Clinical history suggestive of subarachnoid haemorrhage even if CT normal Known vascular access contraindications e.g. femoral bypass surgery, tight ipsilateral carotid stenosis, unsuitable proximal vascular anatomy likely to render endovascular catheterisation difficult or impossible Extracranial ICA occlusion or basilar artery occlusion Alternative intracranial pathology potentially responsible for the new symptoms Medical comorbidities which would preclude safe cerebral vessel catheterisation or which are expected to limit life expectancy to <3 months (eg severe cardiac, renal or hepatic failure, significant coagulopathy, metastatic malignancy) Known allergy to radiological contrast
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiovascular Diseases HIV Simultaneous co-enrollment in the START study Signed informed consent  Inability to ascertain waveform measurements that can be analyzed, i.e. atrial fibrillation